These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 22045356)

  • 1. Prognostic biomarkers in ovarian cancer.
    Huang J; Hu W; Sood AK
    Cancer Biomark; 2010-2011; 8(4-5):231-51. PubMed ID: 22045356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer.
    Nagaraj AB; Joseph P; DiFeo A
    Biomark Med; 2015; 9(3):241-57. PubMed ID: 25731210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
    Ma Z; Wang X; He J; Xia J; Li Y
    PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis.
    Lawrenson K; Mhawech-Fauceglia P; Worthington J; Spindler TJ; O'Brien D; Lee JM; Spain G; Sharifian M; Wang G; Darcy KM; Pejovic T; Sowter H; Timms JF; Gayther SA
    Int J Cancer; 2015 Oct; 137(8):1806-17. PubMed ID: 25204737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression.
    Deng J; Wang L; Chen H; Li L; Ma Y; Ni J; Li Y
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):535-51. PubMed ID: 23609751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic biomarkers in epithelial ovarian cancer.
    Gloss BS; Samimi G
    Cancer Lett; 2014 Jan; 342(2):257-63. PubMed ID: 22245949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Placenta Growth Factor Is Associated with Unfavorable Prognosis of Advanced-Stage Serous Ovarian Cancer.
    Meng Q; Duan P; Li L; Miao Y
    Tohoku J Exp Med; 2018 Apr; 244(4):291-296. PubMed ID: 29643276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AEG -1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers.
    Li C; Liu J; Lu R; Yu G; Wang X; Zhao Y; Song H; Lin P; Sun X; Yu X; Zhang Y; Ning X; Geng J
    Int J Gynecol Cancer; 2011 May; 21(4):602-8. PubMed ID: 21543927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer.
    Wan WN; Zhang YQ; Wang XM; Liu YJ; Zhang YX; Que YH; Zhao WJ; Li P
    Diagn Pathol; 2014 Sep; 9():178. PubMed ID: 25257702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological values of NBS1 and DNA damage response genes in epithelial ovarian cancers.
    Lee YK; Park NH; Lee H
    Exp Mol Med; 2015 Nov; 47(11):e195. PubMed ID: 26584681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of miR-1181 and miR-4314 as serum microRNA biomarkers for epithelial ovarian cancer diagnosis and prognosis.
    Minareci Y; Ak N; Sozen H; Tosun OA; Kucukgergin C; Aydin F; Bingul İ; Salihoglu MY; Topuz S
    Mol Biol Rep; 2024 Apr; 51(1):515. PubMed ID: 38622482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAGE-A family serves as poor prognostic markers and potential therapeutic targets for epithelial ovarian cancer patients: a retrospective clinical study.
    Sang M; Wu X; Fan X; Lian Y; Sang M
    Gynecol Endocrinol; 2017 Jun; 33(6):480-484. PubMed ID: 28277121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer.
    Liu R; Martin TA; Jordan NJ; Ruge F; Ye L; Jiang WG
    Int J Oncol; 2016 Jun; 48(6):2488-96. PubMed ID: 27035883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
    Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
    Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of KIF14 is associated with poor prognosis in patients with epithelial ovarian cancer.
    Qiu HL; Deng SZ; Li C; Tian ZN; Song XQ; Yao GD; Geng JS
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):239-245. PubMed ID: 28165566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of TBC1D16 Is Associated with Favorable Prognosis of Epithelial Ovarian Cancer.
    Yang Z; Shen H; He W; Ouyang L; Guo Y; Qian F; Xu B; Xie D; Yang G
    Tohoku J Exp Med; 2018 Jul; 245(3):141-148. PubMed ID: 29962380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation.
    Dong L; Che H; Li M; Li X
    Med Sci Monit; 2016 Sep; 22():3248-56. PubMed ID: 27623016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma.
    Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M
    J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.